>
US Embassies Across Mideast Are Permanently Reassigning Personnel
GOA Members Make History With First Suppressor Transfers Without NFA Registration Since 1934
Common Blood Pressure Drug Recalled Nationwide, FDA Says
Will AstraZeneca Have to Pay Medical Expenses for Woman Injured During COVID Vaccine Trial?
Vitalik Buterin Says Ethereum Is Betting Its Future On Quantum Security And AI
Everything You Wanted To Know About Building A Cheap AI Setup (That Still Works)...
If They Were Human, They'd Be Arrested. Experts Respond To Rogue AI Breaches
Sodium Ion Batteries Will be 80% Cheaper & Last LONGER!
German startup SAXON Q has introduced a diamond-based quantum computing system...
Elon Musk To Build The Largest Building In The World - 100 Million Square Feet
Bitcoin 'Red Team' Says AI Is Finding 100s Of Critical Exploits Across Core Projects
EG4 Power Pro VS Ruixu Lithi VS Yixiang Budget Battery! Best Selling Battery Showdown!
Insect wings can kill bacteria without any chemicals!
Tesla Never Made An Electric Jet Boat, So This YouTuber Built One Himself
The recall affects one lot of Diovan, Novartis' valsartan brand, according to a report issued last week. The lot includes 160-milligram tablets in 90-count bottles, with the lot number AV5913C, and an expiration date of June 2027.
The drug is prescription-only and manufactured by North Carolina-based Patheon Manufacturing Services LLC and distributed by Novartis, a multinational pharmaceutical company that is one of the largest in the world.
According to the FDA notice, the reason for the recall is due to "failed dissolution specifications," meaning that the pills may not dissolve correctly in the body when ingested.